Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Erratum for Dietrich, Blood 114 (9) 1999.
Blood, 29 October 2009, Vol. 114, No. 18, pp. 3974.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents

ERRATA

Schmitz et al. Response: Intrathecal methotrexate and central nervous system events. Blood. 2009;114(9):1999–2000.

On pages 1999 and 2000 of the August 27, 2009, issue, there are errors in the second letter in Correspondence.

On page 1999, in the first paragraph of the Schmitz et al Response there is an error in attribution. Due to a miscommunication, the authors believed they were responding to a letter to the editor from Brugières and colleagues, rather than a letter from Pierre-Yves Dietrich. The first and second sentences of the Schmitz et al letter should read: "We thank Dr Dietrich for his comments and for pointing out the additional information coming from the Brugières et al study in children and adolescents with anaplastic large-cell lymphoma.1 The author raises important questions, which we would like to answer as follows:"

On page 2000, the name "Dietrich" should replace "Brugières et al" in the seventh sentence of the last paragraph. The correct sentence should read: "Although the low number of such patients in our trial precluded a statistical analysis of whether at least these patients may have benefited from intrathecal MTX we agree with Dietrich that intrathecal MTX was of limited value in the population at large and should no longer be administered, particularly if the side effects are taken into account."


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020